Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and midaglizole

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with midaglizole in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(midaglizole)
Trials
(midaglizole)
Recent Studies (post-2010) (midaglizole)
9,1561875526550

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bewtra, AK; Hopp, RJ; Miyagawa, H; Okada, C; Sugiyama, H; Townley, RG1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and midaglizole

ArticleYear
The effect of a selective alpha 2-adrenergic receptor antagonist (midaglizole) on the cyclic 3',5'-adenosine monophosphate production in human mononuclear cells.
    The Journal of allergy and clinical immunology, 1992, Volume: 89, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adult; Asthma; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Humans; Imidazoles; Isoproterenol; Leukocytes, Mononuclear; Male; Platelet Activating Factor

1992